# Apatinib for the Elderly Advanced Gastric Cancer

> **NCT03104283** · PHASE2 · COMPLETED · sponsor: **Affiliated Hospital of Qinghai University** · enrollment: 48 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Apatinib

## Key facts

- **NCT ID:** NCT03104283
- **Lead sponsor:** Affiliated Hospital of Qinghai University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-05
- **Primary completion:** 2019-12-01
- **Final completion:** 2020-06-02
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2022-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03104283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03104283, "Apatinib for the Elderly Advanced Gastric Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03104283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*